Mass spectrometric analysis of exhaled breath for the identification of volatile organic compound biomarkers in esophageal and gastric adenocarcinoma

Annals of Surgery

Volumn 262, Issue 6, 2015, Pages 981-990

  Kumar, Sacheen ^a   Huang, Juzheng ^a   Abbassi Ghadi, Nima ^a   MacKenzie, Hugh A ^a   Veselkov, Kirill A ^a   Hoare, Jonathan M ^a   Lovat, Laurence B ^b   Spanel, Patrik ^c   Smith, David ^d   Hanna, George B ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c J HEYROVSKÝ INSTITUTE OF PHYSICAL CHEMISTRY   (Czech Republic)

^d KEELE UNIVERSITY   (United Kingdom)

Author keywords

Breath analysis; Esophageal cancer; Gastric cancer; Mass spectrometry; Volatile organic compounds

Indexed keywords

BIOLOGICAL MARKER; BUTYRALDEHYDE; CRESOL; DECANAL; ETHYLPHENOL; HEPTANAL; HEXANAL; HEXANOIC ACID; NONANAL; OCTANAL; PENTANAL; PHENOL; UNCLASSIFIED DRUG; VALERIC ACID; VOLATILE ORGANIC COMPOUND; TUMOR MARKER;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; BENIGN TUMOR; BREATH ANALYSIS; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENDOSCOPIC ECHOGRAPHY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOGASTRODUODENOSCOPY; EXPIRED AIR; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETER; MASS SPECTROMETRY; PREDICTION; PRIORITY JOURNAL; PROBABILITY; RISK ASSESSMENT; SELECTED ION FLOW TUBE MASS SPECTROMETER; SELECTED ION FLOW TUBE MASS SPECTROMETRY; SENSITIVITY AND SPECIFICITY; STOMACH ADENOCARCINOMA; TUMOR VOLUME; UPPER GASTROINTESTINAL TRACT; ADENOCARCINOMA; CASE CONTROL STUDY; CLINICAL TRIAL; DECISION SUPPORT SYSTEM; ESOPHAGEAL NEOPLASMS; EXHALATION; METABOLISM; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; STOMACH NEOPLASMS;

ADENOCARCINOMA; AGED; BIOMARKERS, TUMOR; BREATH TESTS; CASE-CONTROL STUDIES; DECISION SUPPORT TECHNIQUES; ESOPHAGEAL NEOPLASMS; EXHALATION; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; RISK ASSESSMENT; ROC CURVE; STOMACH NEOPLASMS; VOLATILE ORGANIC COMPOUNDS;

EID: 84948709636     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000001101     Document Type: Article

References (35)

1. Jemal A, Bray A, Center MM, et al. Global cancer statistics, 2011. CA Cancer J Clin. 2011;61:69-90.
2. The NHS Information Centre. National esophago-gastric cancer audit 2010. Available at: http://www.hqip.org.uk/assets/NCAPOP-Library/NCAPOP-2013-14/NOGCA-2013-INTERACTIVE-PDF27062013.pdf. Published 2013. Accessed December 13, 2013.
3. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2010. Bethesda, MD: National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975-2010/. Accessed December 12, 2013.
4. Prasad GA, Wu TT, Wigle DA, et al. Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus. Gastroenterology. 2009;137:815-822.
5. Vakil N, Talley NJ, Van Zanten SV, et al. Cost of detecting malignant lesions by endoscopy in 2741 primary care dyspeptic patients without alarm symptoms. Clin Gastroenterol Hepatol. 2009;7:756-761.
6. Vakil N, Moayyedi P, Fennerty MB, et al. Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis. Gastroenterology. 2006;131:390-401.
7. Kawai T, Kawakami K, Kataoka M, et al. A study of the relationship between Helicobacter pylori microbial susceptibility, 13C-urea breath test values. Hepatogastroenterology. 2008;55:786-790.
8. Kerlin P, Wong L. Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology. 1988;95:982-988.
9. Kharitonov SA, Yates D, Robbins RA, et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet. 1994;343:133-135.
10. Pauling L, Robinson AB, Teranishi R, et al. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci USA. 1971;68:2374-2376.
11. Sonoda H, Kohnoe S, Yamazato T, et al. Colorectal cancer screening with odour material by canine scent detection. Gut. 2011;60:814-819.
12. Altomare DF, Di Lena M, Porcelli F, et al. Exhaled volatile organic compounds identify patients with colorectal cancer. Br J Surg. 2013;100: 144-150.
13. Xu ZQ, Broza YY, Ionsecu R, et al. A nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditions. Br J Cancer. 2013;108:941-950.
14. Phillips M, Gleeson K, Hughes JM, et al. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet. 1999;353:1930-1933.
15. Peng G, Hakim M, Broza YY, et al. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br J Cancer. 2010;103:542-551.
16. Zhan X, Duan J, Duan Y. Recent developments of proton-transfer reaction mass spectrometry (PTR-MS) and its applications in medical research. Mass Spectrom Rev. 2013;32:143-165.
17. Smith D, Spanel P. Selected ion flow tube mass spectrometry (SIFT-MS) for on-line trace gas analysis. Mass Spectrom Rev. 2005;24:661-700.
18. Hryniuk A, Ross RM. A preliminary investigation of exhaled breath from patients with celiac disease using selected ion flow tube mass spectrometry. J Gastrointestin Liver Dis. 2010;19:15-20.
19. Endre ZH, Pickering JW, Storer MK, et al. Breath ammonia and trimethyl-amine allow real-time monitoring of haemodialysis efficacy. Physiol Meas. 2011;32:115-130.
20. Huang J, Kumar S, Singanayagam A, et al. Exhaled breath acetone for therapeutic monitoring in pneumonia using selected ion flow tube mass spectrometry (SIFT-MS). Anal Methods. 2013;5:3807-3810.
21. Kumar S, Huang J, Abbassi-Ghadi N, et al. Selected ion flow tube mass spectrometry analysis of exhaled breath for volatile organic compound profiling of esophago-gastric cancer. Anal Chem. 2013;85:6121-6128.
22. Kumar S, Huang J, Cushnir JR, et al. Selected ion flow tube-MS analysis of headspace vapor from gastric content for the diagnosis of gastro-esophageal cancer. Anal Chem. 2012;84:9550-9557.
23. Huang J, Kumar S, Abbassi-Ghadi N, et al. Selected ion flow tube mass spectrometry analysis of volatile metabolites in urine headspace for the profiling of gastro-esophageal cancer. Anal Chem. 2013;85:3409-3416.
24. Shen Q, Fan J, Yang X, et al. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study. Lancet Oncol. 2012;13:817-826.
25. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11-20.
26. Wang L, Chen J, Chen L, et al. 1H-NMR based metabonomic profiling of human esophageal cancer tissue. Mol Cancer. 2013;12:25.
27. Tan B, Qiu Y, Zou X, et al. Metabonomics identifies serum metabolite markers of colorectal cancer. J Proteome Res. 2013;12:3000-3009.
28. Geypens B, Claus D, Evenepoel P, et al. Influence of dietary protein supplements on the formation of bacterial metabolites in the colon. Gut. 1997;41: 70-76.
29. Deng K, Lin S, Zhou L, et al. High levels of aromatic amino acids in gastric juice during the early stages of gastric cancer progression. PLoS One. 2012;7:49434.
30. Fuchs P, Loeseken C, Schubert JK, et al. Breath gas aldehydes as biomarkers of lung cancer. Int J Cancer. 2010;126:2663-2670.
31. Xue R, Dong L, Zhang S, et al. Investigation of volatile biomarkers in liver cancer blood using solid-phase microextraction and gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom. 2008;22:1181-1186.
32. Zhang G, Ma L, Xie YK, et al. Esophageal cancer tumor spheres involve cancer stemlike populations with elevated aldehyde dehydrogenase enzymatic activity. Mol Med Rep. 2012;6:519-524.
33. Mochalski P, Sponring A, King J, et al. Release and uptake of volatile organic compounds by hepatocellular carcinoma cells (HepG2) in vitro. Cancer Cell Int. 2013;13:72.
34. Wang T, Pysanenko A, Dryahina K, et al. Analysis of breath, exhaled via the mouth and nose, and the air in the oral cavity. J Breath Res. 2008;2:037013.
35. Ulanowska A, Kowalkowski T, Hrynkiewicz K, et al. Determination of volatile organic compounds in human breath for Helicobacter pylori detection by SPME-GC/MS. Biomed Chromatogr. 2011;25:391-397.